*ST全新(000007) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥75,695,407.07, representing a 53.08% increase compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was ¥80,064.51, a significant increase of 106.21% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥1,297,686.67, up 108.13% from the previous year[2]. - The basic earnings per share for Q3 2024 was ¥0.0002, an increase of 105.41% year-on-year[2]. - The diluted earnings per share for Q3 2024 was also ¥0.0002, marking a 105.41% increase compared to the same period last year[2]. - Total operating revenue for Q3 2024 was CNY 154,225,694.46, a slight increase from CNY 153,301,309.11 in Q3 2023, representing a growth of approximately 0.6%[23]. - Net profit for Q3 2024 was CNY 1,639,435.32, down from CNY 8,012,483.91 in Q3 2023, reflecting a decrease of approximately 79.5%[24]. - The net profit attributable to the parent company for Q3 2024 was CNY 3,176,090.93, a decrease from CNY 10,847,119.51 in the same period last year[25]. - The total comprehensive income attributable to the parent company was CNY 3,176,090.93, compared to CNY 10,847,119.51 in the previous year[25]. - The basic and diluted earnings per share for Q3 2024 were both CNY 0.0092, down from CNY 0.0313 in the same quarter last year[25]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥20,583,581.13, down 83.19% compared to the same period last year[2]. - The company reported a significant decrease in cash and cash equivalents, with a net decrease of ¥80,423,251.53 for the year-to-date period[6]. - As of September 30, 2024, the company's cash and cash equivalents amounted to ¥112,792,802.71, down from ¥193,152,475.45 at the beginning of the period, indicating a decrease of approximately 41.6%[20]. - The company’s cash and cash equivalents were not explicitly detailed, but the total current assets decreased to CNY 214,330,463.11 from CNY 278,872,131.16, indicating a decline of approximately 23%[21]. - The cash and cash equivalents at the end of Q3 2024 were CNY 112,640,597.74, down from CNY 167,923,152.22 at the end of the previous year[28]. - The company reported a total cash decrease of CNY 80,423,251.53 for the quarter, contrasting with an increase of CNY 4,328,951.08 in the same period last year[28]. Assets and Liabilities - Total assets at the end of Q3 2024 were ¥332,221,133.29, a decrease of 16.58% from the end of the previous year[2]. - The equity attributable to shareholders at the end of Q3 2024 was ¥128,936,086.76, reflecting a 2.53% increase from the end of the previous year[2]. - Total liabilities decreased to CNY 192,558,493.84 from CNY 260,206,361.85, reflecting a reduction of about 26%[22]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,917[7]. - The largest shareholder, Hanfu Holdings Limited, holds 12.99% of shares, totaling 45,000,127 shares[7]. - Shenzhen Boheng Investment Co., Ltd. holds 10.82% of shares, totaling 37,500,000 shares[7]. - The top ten shareholders include several significant investors, with the top three holding a combined 33.59% of shares[7]. - The company has not reported any changes in the shareholding structure of the top ten shareholders due to margin trading activities[8]. Legal Matters - The company is involved in an arbitration case, which has been resolved with a settlement agreement reached on August 28, 2024[12]. - The company has reached a settlement with Xie Chu'an regarding a series of legal cases, resulting in debt offset and withdrawal of lawsuits, with relevant legal documents received[13]. - The company is involved in a lawsuit initiated by Guangzhou He Ren Industrial Co., Ltd. for a total claim of ¥4,049,115.30, which includes principal and interest for surplus distribution disputes[14]. - The company’s subsidiary, Shenzhen Guangbo Investment Development Co., Ltd., is facing a lawsuit related to surplus distribution, with the court currently in the process of mediation[14]. - The company has been listed as a dishonest entity due to a historical debt issue, but recent court rulings have lifted the consumption restrictions[16]. - The company’s financial liabilities and ongoing legal disputes may impact its liquidity and operational strategies moving forward[14][16]. - The company has not yet resolved the financial implications of the ongoing lawsuit regarding surplus distribution, pending court judgment[14]. Operational Developments - The company reduced the registered capital of its subsidiary, Yancheng New City Fude Automobile Sales Service Co., Ltd., from RMB 56 million to RMB 37.56 million[9]. - The company established a wholly-owned subsidiary, Zhejiang Quanxinhao Pharmaceutical Co., Ltd., with an investment of RMB 10 million to explore new profit growth points[9]. - The company provided a guarantee of RMB 80 million for its subsidiary, with RMB 17,643,118.20 utilized during the reporting period[10]. - The company’s subsidiary, Zero Degree Health (Shenzhen) Co., Ltd., provided a guarantee of RMB 6.3 million, with RMB 1,856,961.00 utilized during the reporting period[10]. - The company completed the acquisition of 100% equity in Nantong Yaozhong Automobile Co., Ltd. for ¥15.53 million, based on a net asset valuation of ¥15,533,015.89[19].